Thomas P Stossel

This inventor holds 22 USPTO granted patents and 6 published patent applications, plus 7 CIPO patents and 8 EPO patents. Top assignees: The Brigham and Women's Hospital, Inc., Beth Israel Deaconess Medical Center, Inc., The General Hospital Corporation. Active years: 1993-2026.

USPTO Granted Patents = 22 (Patent Applications = 6)

% Patents Active = 81.8

CIPO Patents = 7 (Patent Applications = 3)

EPO Patents = 8 (Patent Applications = 4)

Average Co-Inventor Count = 3.4

ph-index = 10

Forward Citations = 271(Granted Patents)

Location History:

Boston, MA (US) (2017)
Belmont, MA (US) (1993 - 2019)

Company Filing History:

18 out of 1,422

The Brigham and Women's Hospital, Inc.

patents

2 out of 536

Beth Israel Deaconess Medical Center, Inc.

patents

2 out of 3,068

The General Hospital Corporation

Bioaegis Therapeutics Inc.

Bloodcenter Research Foundation

patents

8. 1 out of 1,072

Children's Medical Center Corporation

11. 1 out of 834,350

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721880 - Methods and compositions for treating frailty (2026-09-01),

2. 10272136 - Diagnostic and therapeutic uses of gelsolin in renal failure (2019-04-30),

3. 10238715 - Methods for treating or reducing the risk of arthritis in a subject by administering gelsolin (2019-03-26),

4. 10022424 - Use of gelsolin to treat infections (2018-07-17),

5. 9678088 - Multiphase systems for diagnosis of sickle cell disease (2017-06-13),

6. 9575072 - Diagnostic and therapeutic uses of gelsolin in renal failure (2017-02-21),

7. 9316639 - Use of gelsolin to diagnose and treat inflammatory diseases (2016-04-19),

8. 8440622 - Use of gelsolin to treat multiple sclerosis and to diagnose neurologic disease (stossel) (2013-05-14),

9. 8221745 - Prolonging survival of platelets using CMP-sialic acid,UDP-galactose or both (2012-07-17),

10. 8198094 - Methods of using gelsolin levels to characterize a subject's risk of developing rheumatoid arthritis (2012-06-12),

11. 7858295 - Methods for prolonging survival of platelets using UDP-galactose (2010-12-28),

12. 7241282 - Compositions and methods for prolonging survival of platelets (2007-07-10),

13. 5876676 - Preservation of blood platelets (1999-03-02),

14. 5846743 - Polyphoshoinositide binding peptides for intracellular drug delivery (1998-12-08),

15. 5783662 - Polyphosphoinsitide binding peptides for intracellular drug delivery (1998-07-21),

Title: The Innovative Journey of Thomas P Stossel

Introduction: Thomas P Stossel, a distinguished inventor hailing from Belmont, MA (US), has made significant contributions to the field of medicine through his groundbreaking innovations.

Latest Patents: Thomas P Stossel holds several patents related to medical devices and treatments, showcasing his ongoing commitment to advancing healthcare technologies.

Career Highlights: With a career spanning several decades, Thomas P Stossel has held prominent positions in research institutions and universities, where he has spearheaded numerous projects that have revolutionized the medical industry.

Collaborations: Throughout his career, Thomas P Stossel has collaborated with leading experts in the medical field, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in healthcare.

Conclusion: Thomas P Stossel's relentless pursuit of innovation and his passion for improving patient care have solidified his reputation as a pioneering inventor in the medical field.